Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1111-1120 of 2905 for cancer

Edit search filters
  1. Efficacy Of [18F]PSMA-1007 PET/CT In Patients With Biochemial Recurrent Prostate Cancer

    Rochester, MN

  2. Olaparib In Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study Of Four-Dimensional MRI For Image-Guided Radiation Therapy

    Scottsdale/Phoenix, AZ

  4. Remote Monitoring For Lifestyle Changes In Patients With Lung Cancer Related Fatigue

    Rochester, MN

  5. Early Integrated Telehealth Versus In-Person Palliative Care For Patients With Lung Cancer

    Rochester, MN

  6. Study Of Magrolimab Combination Therapy To Treat Unresectable, Locally Advanced Or Metastatic Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Pembrolizumab With Chemotherapy And With/Without MK-4830 For Treating Participants With Ovarian Cancer

    Jacksonville, FL

  8. DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas

    Rochester, MN

  9. Oral Ketamine in the Treatment of Depression and Anxiety in Patients with Cancer

    Scottsdale/Phoenix, AZ

  10. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

    Rochester, MN

.

Mayo Clinic Footer